A comparison between clinical decisions made about lung cancer patients and those inherent in the corresponding Scottish Intercollegiate Guidelines Network (SIGN) guideline

Glaucoma-service provision in Scotland: introduction and need for Scottish Intercollegiate Guidelines Network guidelines

PURPOSE To describe the pattern of glaucoma-service delivery in Scotland and identify areas for improvement, taking into account Scottish General Ophthalmic Services (GOS) arrangements and the Eye Care Integration project, and to design Scottish Intercollegiate Guidelines Network (SIGN) guidelines to refine the primary and secondary interface of glaucoma care. MATERIALS AND METHODS A glaucoma...

Scottish Intercollegiate Guidelines Network: the first 15 years (1993-2008).

The Scottish Intercollegiate Guidelines Network (SIGN) was established in 1993. One of the first national programmes of evidence-based clinical practice guidelines, it has played a lead role internationally in many of the developments in guideline methodology. The challenges faced from the beginning of the organisation up to its integration into the National Health Service and how they were add...

Differential research impact in cancer practice guidelines’ evidence base: lessons from ESMO, NICE and SIGN

Background This is an appraisal of the impact of cited research evidence underpinning the development of cancer clinical practice guidelines (CPGs) by the professional bodies of the European Society for Medical Oncology (ESMO), the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). Methods A total of 101 CPGs were identified fr...

COPD Evidence Tables The evidence tables are presented in section order. The methodological quality of each paper was rated using the Scottish Intercollegiate Guidelines Network (SIGN) system (Scottish Intercollegiate Guidelines Network. SIGN

A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer

Cancer constitutes a huge burden on societies in countries with any level of economic development. Prostate cancer is the first most diagnosed cancer of men in developed countries and the forth one in developing countries in terms of incidence rate. It is also the third incident cancer of men in Iran along with a prevalence of about 10,000 cases. Castration-resistant prostate cancer (CRPC) is a...